G. Barbara; L. Gargano; C. Cremon; V. Vasina; G. Dothel; G. Carini; R. De Giorgio; V. Stanghellini; R. Cogliandro; M. Tonini; F. De Ponti; R. Corinaldesi, Nerve Growth and Plasticity in the Colonic Mucosa of Patients With Irritable Bowel Syndrome, in: , «GASTROENTEROLOGY», 2010, 138, pp. S65 - S65 (atti di: Congresso American Gastroenterological Association, New Orleans - USA, Maggio 2010) [Abstract]
Vasina V.; Broccoli M.; Ursino M.G.; Canistro D.; Valgimigli L.; Soleti A.; Paolini M.; De Ponti F., Non-peptidyl low molecular weight radical scavenger IAC attenuates DSS-induced colitis in rats., «WORLD JOURNAL OF GASTROENTEROLOGY», 2010, 16, pp. 3642 - 3650 [Scientific article]
Ferrier L.; Serradei-Le Gal C.; Schulte A.M.; Vasina V.; Gaultier E.; Schroedel S.; Ursino M.G.; Chaumaz G.; Pascal M.; De Ponti F.; Bueno L., Proinflammatory role of vasopressn through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD, «AMERICAN JOURNAL OF PHYSIOLOGY: GASTROINTESTINAL AND LIVER PHYSIOLOGY», 2010, 299, pp. G1298 - G1307 [Scientific article]
Boriani G; Diemberger I; Valzania C; Biffi M; Martignani C; Raschi E; Mantovani V; Ziacchi M; Bertini M; De Ponti F; Branzi A., Role of drugs and devices in patients at risk of sudden cardiac death., «FUNDAMENTAL & CLINICAL PHARMACOLOGY», 2010, 24, pp. 575 - 594 [Scientific article]
E. Raschi; E. Poluzzi; U. Moretti; F. De Ponti, TdP liability of fluoroquinolones: integrated approach based on the FDA spontaneous reports and literature data., in: Supplement: Abstracts from the 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Rhode Island Convention Center, Providence, Rhode Island, USA. August 16–19, 2009, «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2010, 19, pp. S1 - S347 (atti di: 25th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Brighton, August 17-22) [Abstract]
E. Poluzzi; E. Raschi; D. Motola; U. Moretti; F. De Ponti, Antimicrobial-induced torsades de pointes: towards risk stratification by data mining of the FDA Adverse Event Reporting System., «BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY», 2009, 105, pp. 31 - 31 [Scientific article]
Coordination of a Research Project: ARITMO.
Poluzzi E; Raschi E; Moretti U; De Ponti F., Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)., «PHARMACOEPIDEMIOLOGY AND DRUG SAFETY», 2009, 18, pp. 512 - 518 [Scientific article]
Vasina V.; Broccoli M.; Ursino M.G.; Bellot S.F.; Soleti A.; Paolini M.; De Ponti F., Effects of the non-peptidyl low molecular weight radical scavenger IAC in DNBS-induced colitis in rats., «EUROPEAN JOURNAL OF PHARMACOLOGY», 2009, 614, pp. 137 - 145 [Scientific article]
Raschi E; Poluzzi E; Zuliani C; Muller A; Goossens H; De Ponti F., Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period., «BRITISH JOURNAL OF CLINICAL PHARMACOLOGY», 2009, 67, pp. 88 - 98 [Scientific article]
Raschi E.; Ceccarini L.; De Ponti F.; Recanatini M., hERG-related drug toxicity and models for predicting hERG liability and QT prolongation, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2009, 5, pp. 1005 - 1021 [Scientific article]
Ursino M.G.; Vasina V.; De Ponti F., Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats, «EUROPEAN JOURNAL OF PHARMACOLOGY», 2009, 603, pp. 133 - 137 [Scientific article]
Sinagra G.; Patrono C.; De Ponti F., Reazioni avverse cardiovascolari, in: Reazioni avverse a farmaci: sospetto e diagnosi, MILANO, Cortina, 2009, pp. 65 - 90 [Chapter or essay]
Pagliaro L.; De Ponti F., Reazioni avverse epatiche, in: Reazioni avverse a farmaci: sospetto e diagnosi, MILANO, Cortina, 2009, pp. 143 - 162 [Chapter or essay]
Ursino M.G.; Vasina V.; Raschi E.; Crema F.; De Ponti F., The beta3-adrenoceptor as a therapeutic target: current perspectives., «PHARMACOLOGICAL RESEARCH», 2009, 59, pp. 221 - 234 [Scientific article]
